Carotenuto, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 556
EU - Europa 377
AS - Asia 179
AF - Africa 14
OC - Oceania 2
Totale 1.128
Nazione #
US - Stati Uniti d'America 552
IT - Italia 243
SG - Singapore 122
NL - Olanda 52
CN - Cina 25
SE - Svezia 23
UA - Ucraina 16
CI - Costa d'Avorio 14
VN - Vietnam 12
GB - Regno Unito 11
IN - India 8
DE - Germania 7
FR - Francia 7
FI - Finlandia 5
IE - Irlanda 5
CA - Canada 4
HK - Hong Kong 3
KR - Corea 3
PK - Pakistan 3
AU - Australia 2
GR - Grecia 2
ID - Indonesia 2
AT - Austria 1
BE - Belgio 1
CH - Svizzera 1
LV - Lettonia 1
PL - Polonia 1
SI - Slovenia 1
TR - Turchia 1
Totale 1.128
Città #
Chandler 100
Singapore 100
Naples 98
Ashburn 64
Amsterdam 48
Millbury 32
Santa Clara 24
Lawrence 22
Orta di Atella 20
Jacksonville 15
Dong Ket 12
Woodbridge 12
Napoli 11
Seattle 10
Wilmington 10
Pune 6
Dallas 5
Des Moines 5
Ercolano 5
Houston 5
London 5
Milan 5
Rome 5
Washington 5
Beijing 4
Los Angeles 4
Venice 4
Boardman 3
Boston 3
Dublin 3
Fairfield 3
Hong Kong 3
Lahore 3
Portici 3
Princeton 3
Birmingham 2
Boscoreale 2
Carife 2
Formia 2
Giugliano in Campania 2
Jiaxing 2
Jinhua 2
Lucca 2
Nanjing 2
Parabiago 2
Poli 2
Pozzuoli 2
Reggio Emilia 2
Scafati 2
Seoul 2
Torre del Greco 2
Afragola 1
Albano Sant'Alessandro 1
Amgaon 1
Athens 1
Bari 1
Brussels 1
Cambridge 1
Cascina 1
Castellammare di Stabia 1
Changsha 1
Chicago 1
Elora 1
Felitto 1
Fort Worth 1
Grumo Nevano 1
Gurgaon 1
Gyeyang-gu 1
Helsinki 1
Kunming 1
Leipzig 1
Liaocheng 1
Linyi 1
Miami 1
Munich 1
Nagold 1
Nanning 1
Norwalk 1
Orange 1
Ottawa 1
Parma 1
Pavia 1
Pergine Valsugana 1
Philadelphia 1
Prineville 1
Redwood City 1
Riga 1
Salerno 1
San Francisco 1
Sandston 1
Savignano Sul Panaro 1
Secaucus 1
Shenzhen 1
Springfield 1
Taizhou 1
Tianjin 1
Toronto 1
Vienna 1
Volla 1
Wandsworth 1
Totale 741
Nome #
Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. 102
Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma 69
PRUNE and NM23-M1 expression in Embryonic and Adult Mouse Brain. 65
Pemiganitib. Fibroblast growth factor receptor inhibitor, Treatment of cholangiocarcinoma. 54
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 50
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 46
Thyroid Cancer and Fibroblasts 44
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 44
Therapeutic Approaches Targeting Nucleolus in Cancer. 43
The pervasive role of the MiR-181 family in development, neurodegeneration, and cancer 39
JTESS (Telencephalic Embryonic Subtractive Sequences): a Unique Collection of Neurodevelopmental Genes. 37
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis 33
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 33
Histone Deacetylase SIRT1 promotes loss of primary cilia in Cholangiocarcinoma 31
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma 29
Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach 29
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 29
New therapeutic strategies for drug-resistant melanoma 28
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 27
A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation 26
Optimizing response to gefitinib in the treatment of non-small-cell lung cancer 25
The evolving role of fgfr2 inhibitors in intrahepatic cholangiocarcinoma: From molecular biology to clinical targeting 23
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 22
Characterisation of the immune-related transcriptome in resected biliary tract cancers 21
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma 21
Spatial and temporal expressions of prune reveal a role in Müller gliogenesis during Xenopus retinal development 20
Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay 19
Prognostic applications of gene expression signatures in breast cancer 17
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 16
Vandetanib: An overview of its clinical development in NSCLC and other tumors 16
Noncoding RNAs as novel biomarkers in pancreatic cancer: What do we know? 16
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 15
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 13
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 12
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 12
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 11
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 10
Triple negative breast cancer: From molecular portrait to therapeutic intervention 10
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth 9
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 9
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 8
Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies 8
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 7
Ribosomal protein uL3 as regulator of ferroptosis in 5-FU resistance 6
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 5
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy 5
NEW THERAPEUTIC STRATEGIES FOR DRUG-RESISTANT MELANOMA 4
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 4
Totale 1.222
Categoria #
all - tutte 6.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 10 0 2 0 0 10 6 12
2020/2021106 2 3 12 6 7 21 4 1 17 11 9 13
2021/2022118 4 4 0 2 0 2 0 5 26 21 9 45
2022/2023337 25 8 8 9 45 49 5 38 58 49 32 11
2023/2024319 14 39 51 15 18 41 12 30 7 10 63 19
2024/2025265 50 39 8 101 67 0 0 0 0 0 0 0
Totale 1.222